CHICAGO, November 13, 2025 — Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), today announced the launch of Cresco-branded flower in Germany, marking the Company’s first commercial entry into the European Union. The launch reflects Cresco’s expanded growth strategy as it pilots new investment platforms beyond U.S. cannabis.
Germany is one of the world’s fastest-growing regulated cannabis markets, supported by a well-structured regulatory framework and an expanding patient base. The launch serves as an opportunity to gather insights while building a foundation for Cresco Labs’ future expansion potential in international markets.
“After extensive work understanding the European landscape, we’re confident that Cresco can deliver meaningful value through our portfolio of market leading brands, proven operational capabilities, and deep experience operating in dynamic regulatory environments,” said Charlie Bachtell, CEO of Cresco Labs. “Our objective is to use these insights to guide future growth decisions in evolving markets.”
Cresco Labs is partnering with Blossom, the Company’s EU GMP-certified manufacturing partner in Portugal, to introduce three signature flower products, each aligned with specific patient effects.
Cresco products are now available via prescription through licensed pharmacies across Germany.